STAGE III SINONASAL CANCER AJCC V8
Clinical trials for STAGE III SINONASAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III SINONASAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III SINONASAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost chemoradiation for head and neck cancer
Disease control Recruiting nowThis early-phase trial is testing whether adding the drug ipatasertib to standard chemotherapy and radiation can better control advanced head and neck cancer. Ipatasertib is a targeted therapy that may stop cancer cells from growing. The study involves about 46 adults with certai…
Matched conditions: STAGE III SINONASAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New combo therapy aims to shrink hard-to-treat sinus tumors before surgery
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug cemiplimab to standard chemotherapy before surgery can better control sinonasal squamous cell cancer. About 108 adults with stage III or IV sinus cancer will be randomly assigned to receive either chemotherapy alone or chemot…
Matched conditions: STAGE III SINONASAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:39 UTC